DLHCX
Price
$20.56
Change
-$0.02 (-0.10%)
Updated
Jul 3 closing price
Net Assets
649.97M
FSPHX
Price
$25.67
Change
+$0.07 (+0.27%)
Updated
Jul 3 closing price
Net Assets
5.92B
Interact to see
Advertisement

DLHCX vs FSPHX

Header iconDLHCX vs FSPHX Comparison
Open Charts DLHCX vs FSPHXBanner chart's image
Macquarie Healthcare C
Price$20.56
Change-$0.02 (-0.10%)
VolumeN/A
Net Assets649.97M
Fidelity Select Health Care
Price$25.67
Change+$0.07 (+0.27%)
VolumeN/A
Net Assets5.92B
DLHCX vs FSPHX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
DLHCX vs. FSPHX commentary
Jul 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DLHCX is a Buy and FSPHX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FSPHX has more cash in the bank: 5.92B vs. DLHCX (650M). FSPHX pays higher dividends than DLHCX: FSPHX (0.02) vs DLHCX (0.00). DLHCX was incepted earlier than FSPHX: DLHCX (15 years) vs FSPHX (44 years). DLHCX (2.00) is less costly to investors than FSPHX (0.63). FSPHX is a more actively managed with annual turnover of: 40.00 vs. DLHCX (5.00). FSPHX has a lower initial minimum investment than DLHCX: FSPHX (0) vs DLHCX (1000). FSPHX annual gain was more profitable for investors over the last year : -9.98 vs. DLHCX (-16.22). FSPHX return over 5 years is better than : -15.46 vs. DLHCX (-21.88).
DLHCXFSPHXDLHCX / FSPHX
Total Expense Ratio1.960.63311%
Annual Report Gross Expense Ratio2.000.63317%
Fund Existence15 years44 years-
Gain YTD-2.002-5.79835%
Front LoadN/AN/A-
Min. Initial Investment10000-
Min. Initial Investment IRAN/AN/A-
Net Assets650M5.92B11%
Annual Yield % from dividends0.000.02-
Returns for 1 year-16.22-9.98163%
Returns for 3 years-13.97-0.602,319%
Returns for 5 years-21.88-15.46142%
Returns for 10 years1.108.5213%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AGIO36.070.72
+2.04%
Agios Pharmaceuticals
HAFC26.520.48
+1.84%
Hanmi Financial Corp
QNCX1.610.01
+0.62%
Quince Therapeutics
BMRN57.500.33
+0.58%
BioMarin Pharmaceutical
VTAK0.23-0.01
-4.71%
Catheter Precision